My watch list
my.chemeurope.com  
Login  

26 Current news

rss
matching the following criteria

DSM and Chemtrix sign collaboration agreement in Continuous Flow Chemistry

21-02-2013

DSM Pharmaceutical Products announced that it has signed a collaboration agreement with Chemtrix B.V. in the field of Continuous Flow Chemistry to provide sustainable equipment and, development and manufacturing services to the pharmaceutical industry. The agreement brings together the ...

more

Ionic liquids could aid in the delivery of active pharmaceutical compounds in the body

23-01-2013

US scientists have provided a strategy to improve the properties of active pharmaceutical ingredients (APIs) by combining ionic liquids (used to improve the properties of solid APIs) with prodrugs (used to improve solubility, permeability and bioavailability of APIs). The prodrug ionic ...

more

USC scientists turn a harmful greenhouse gas into a tool for making pharmaceuticals

New technique finds a use for ozone-destroying chemical waste product

13-12-2012

A team of chemists at USC has developed a way to transform a hitherto useless ozone-destroying greenhouse gas that is the byproduct of Teflon manufacture and transform it into reagents for producing pharmaceuticals. The team will publish their discovery in Science. The method is also being ...

more

ChemAxon's New US East Coast Headquarters Open in Cambridge, MA

27-09-2012

ChemAxon announces the opening of its new US East Coast headquarters in Cambridge, MA. Located at the heart of Boston's biotechnology hub, these new offices will concentrate technical, scientific and consultancy support as well as business development operations. ChemAxon is also recruiting ...

more

Red wine compound could help seniors walk away from mobility problems

21-08-2012

In a stride toward better health in later life, scientists reported that resveratrol, the so-called "miracle molecule" found in red wine, might help improve mobility and prevent life-threatening falls among older people. The finding, believed to be the first of its kind, was presented at the ...

more

'Heroes of Chemistry': Developed new drugs and technology to cut heating and cooling bills

21-08-2012

The scientists behind three inventions that touch the lives of millions of people around the world will be inducted into a coveted scientific "Hall of Fame" as the latest Heroes of Chemistry named by the American Chemical Society (ACS. The ceremony, held at the 244th ACS National Meeting & ...

more

Roland Berger Strategy Consultants is expanding its Pharma & Chemicals Competence Center in Boston

11-07-2012

To better support its clients and tackle the special challenges of the pharmaceuticals and chemicals industry, Roland Berger Strategy Consultants is stepping up its consulting activities in this sector in North America. "The international pharmaceuticals and chemicals industry has reached a ...

more

Lonza to acquire Arch Chemicals

13-07-2011

Lonza Group Ltd and Arch Chemicals, Inc. announced that they have signed an agreement pursuant to which Lonza has agreed to commence a tender offer for 100 percent of Arch Chemicals’ outstanding shares of common stock at a price of USD 47.20 per share in cash. Lonza’s offer represents a 36.7% ...

more

New organic catalyst should enhance drug research and development

13-05-2011

A new "organocatalyst" developed at Oregon State University is now available for commercial use. Produced by an Albany, Ore., pharmaceutical company, it should make new drug development around the world less costly, more efficient and more environmentally friendly.This catalyst, named "Hua ...

more

International research award goes to Dr. Karl Kolter

Industry Research Achievement in Excipient Technology Award honors long-standing research excellence in the area of novel pharmaceutical excipients

22-11-2010

Dr. Karl Kolter, BASF Head of Pharmaceutical Excipients Research and Development was honored at the AAPS Annual Meeting and Exposition with the 2010 International Pharmaceutical Excipients Council Foundation (IPEC) Industry Research Achievement in Excipient Technology. Dr. Kolter received the ...

more

Page 1 From 3
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE